Genentech’s ocrelizumab shows efficacy in phase III trial
September 30, 2015Research and Development Genentech, MS, Roche, ocrelizumab
Roche subsidiary Genentech has announced positive results from a pivotal phase III study of its investigational medicine ocrelizumab in people …
Heptares awarded $5.5 million grant to combat cocaine addiction
September 30, 2015Research and Development Heptares
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, has been awarded a grant from the National Institute …
Roche says Esbriet shown to extend lives of IPF patients
September 30, 2015Medical Communications, Research and Development, Sales and Marketing Esbriet, Roche, idiopathic pulmonary fibrosis
Roche has presented new clinical data and abstracts on Esbriet (pirfenidone) in the treatment of idiopathic pulmonary fibrosis (IPF), showing …
Featured market report: US pharmaceutical market to 2018
September 29, 2015Manufacturing and Production, Sales and Marketing market reports
This report forecasts US pharmaceutical (prescription and over-the-counter) shipments and demand at the manufacturers’ level, to 2018.This industry forecast report …
New study reveals true impact of severe asthma in Europe
September 29, 2015Research and Development ERS2015, asthma
The results of a new, comprehensive survey have revealed the true burden of severe asthma faced by patients across Europe. …
It’s finally here: 3D-printed pills and technology in pharma
September 29, 2015Manufacturing and Production 3-D printing, 3d printing, Aprecia, Spritam, manufacturing, production
The notion of tailor-made drugs, which are customised to an individual patient’s needs, has seen remarkable progress of late. This …
Georges Gemayel appointed non-executive chairman of Enterome
September 29, 2015Manufacturing and Production
Drug and diagnostics development firm Enterome Bioscience SA has appointed Dr Georges Gemayel to the Enterome board as a non-executive …
UN calls on pharma industry to make medicines more affordable
September 29, 2015Manufacturing and Production AIDS, HIV, Michel Sidibe, UNAIDS, United Nations, antiretroviral treatments
The United Nations AIDS agency, UNAIDS, has called on governments and the pharmaceutical industry to ensure that medicines remain accessible …
FDA withdraws approval for Sun Pharma’s epilepsy drug
September 29, 2015Manufacturing and Production Elepsia, FDA, Sun Pharma, epilepsy, levetiracetam, manufacturing, productions, seizures
Manufacturing problems at Sun Pharma’s production site has led the FDA to revoke the company’s approval for Elepsia XR for …
Bristol-Myers Squibb notches kidney cancer first with Opdivo
September 28, 2015Research and Development Afinitor, Bristol-Myers Squibb, Kidney cancer, advanced kidney cancer, everolimus, nivolumab, opdivo, renal cell carcinoma
Bristol-Myers Squibb has announced positive results from a Phase III study comparing Opdivo to Afinitor, the Novartis treatment that is …
Alexion to challenge Canadian price of Soliris in court
September 28, 2015Sales and Marketing Alexion, Canada, Drug pricing, Patented Medicine Prices Review Board, eculizumab, soliris
Alexion Pharmaceuticals is taking the Canadian government to court for its attempt to lower the price of the rare disease …
Sanofi and Regeneron given European nod for Praluent
September 28, 2015Sales and Marketing European Commission, Regeneron, Sanofi, alirocumab, high cholesterol, marketing authorisation, praluent
The European Commission (EC) has approved the marketing authorisation of Sanofi and Regeneron’s cholesterol drug Praluent. The heart drug is …
FDA approves Novo Nordisk’s diabetes drugs
September 28, 2015Sales and Marketing FDA, Novo Nordisk, Ryzodeg, Tresiba, diabetes, insulin
The FDA has approved two Novo Nordisk drugs, Tresiba and Ryzodeg, for the treatment of type 2 diabetes in adults.The …
Brandicourt set to continue Sanofi restructure
September 28, 2015Sales and Marketing Merial, Sanofi, olivier brandicourt, restructuring, sales, spin-off
Sanofi chief executive Olivier Brandicourt is considering sales or spin-offs of a number of the company’s divisions, as part of …
Legal analysis: compliance top of the agenda for big pharma
September 25, 2015Medical Communications, Sales and Marketing lawyers, legal, pharma industry, reputation
Do you think big pharma suffers from a negative image, and if so, to what extent do you think this …
Synergy Vision shortlisted for Women of the Future awards
September 25, 2015Medical Communications Synergy Vision, medical communications, medical communications agency, women, women of the future awards
Synergy Vision has been shortlisted for the Women of the Future (“WOF”) Awards, the movement recognising and nurturing young female …
ImmunoCellular awarded $19.9 million grant for ICT-107 phase 3 trial for glioblastoma
September 25, 2015Research and Development California Institute for Regenerative Medicine, Cancer, ICT-107, brain cancer, glioblastoma
ImmunoCellular Therapeutics has been awarded a $19.9 million grant by California Institute for Regenerative Medicine (CIRM), California’s stem cell agency, …
Novartis’ new heart failure medicine recommended for EU approval
September 25, 2015Medical Communications, Research and Development Entresto, Novartis, eams, heart failure
The Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Novartis’s heart failure medication Entresto …
Merck and Wayra to tackle NHS funding gap with startup rewards programme
September 25, 2015Research and Development MSD, Merck
Merck Sharpe and Dohme (MSD) and Wayra Open Future, Telefonica’s digital start up accelerator, are investing in digital innovation in …
ABPI responds to UK medicines cost controversy
September 25, 2015Medical Communications, Sales and Marketing ABPI, Cancer Drugs Fund, NHS
Alison Clough, acting CEO of the Association of the British Pharmaceutical Industry (ABPI), has responded to recent reports in the …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
